SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-188036
Filing Date
2015-05-14
Accepted
2015-05-14 16:16:37
Documents
2
Period of Report
2015-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926029d8k.htm 8-K 15542
2 EX-99.1 d926029dex991.htm EX-99.1 40509
  Complete submission text file 0001193125-15-188036.txt   57318
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 15863071
SIC: 2835 In Vitro & In Vivo Diagnostic Substances